91
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the lar.

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inflammatory arthritis needs infectious disease screening before starting a biologic agent, however, few data are known about migrant patients, who represent a peculiar population which requires a multidisciplinary approach among international health specialists and should also be considered by health authorities. For this reason, the Italian and Spanish Societies of Rheumatology (SIR and SER) and Tropical Medicine (SIMET and SEMTSI) promoted a multidisciplinary task force in order to produce specific recommendations about screening and advices to be considered in migrant patients with inflammatory arthritis candidate to receive biological therapy, according to their geographical origin.

          Related collections

          Author and article information

          Journal
          Clin. Exp. Rheumatol.
          Clinical and experimental rheumatology
          0392-856X
          0392-856X
          May 08 2017
          Affiliations
          [1 ] SOD Malattie Infettive e Tropicali, Careggi Hospital, Florence, Italy.
          [2 ] Rheumatology Unit, Department of Medical Sciences, University of Ferrara, and Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy.
          [3 ] Barcelona Institute for Global Health (ISGlobal-CRESIB), Hospital Clínic, Universitat de Barcelona, Spain.
          [4 ] Division of Rheumatology, Hospital Virgen del Puerto, Plasencia, Spain.
          [5 ] Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy.
          [6 ] Division of Rheumatology, University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy.
          [7 ] Department of Internal Medicine and Medical Specialties, Rheumatology Unit, Sapienza University, Rome, Italy.
          [8 ] Department of Medicine, Universidad de La Laguna, Division of Rheumatology, Hospital Universitario de Canarias, La Laguna, Spain.
          [9 ] Servicio de Reumatologia, Hospital Universitario de Mostoles. Madrid, Spain.
          [10 ] Research Unit, Spanish Society of Rheumatology, Madrid, Spain.
          [11 ] Infectious Diseases Unit, University Hospital of Trieste, Italy.
          [12 ] Division of Rheumatology, San Camillo Hospital, Rome, Italy.
          [13 ] General Directorate, San Camillo Hospital, Rome, Italy.
          [14 ] Division of Rheumatology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Spain.
          [15 ] University Department of Infectious and Tropical Diseases, University of Brescia and Brescia Spedali Civili General Hospital, Italy.
          [16 ] Unidad de Vacunación Internacional, Instituto Hispalense de Pediatría, Granada; and Spanish Society of Tropical Medicine and International Health, Spain.
          [17 ] Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Italy. marco.matuccicerinic@unifi.it.
          Article
          11322
          28516869
          62677d14-26b6-4edf-84ad-7c1c5cf5a696
          History

          Comments

          Comment on this article